전이성 난소암에서 Cytokeratin 7과 20의 발현의 임상적 유용성 = Clinical Usefulness of Cytokeratin 7 and 20 Expression in Metastatic Ovarian Tumors

참고문헌 (Reference)

1 Loy T.S, "Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas." 102 : 764-767, 1994

2 Ramaekers F, "Use of monoclonal antibodies to keratin 7 in differential diagnosis of adenocarcinomas." 136 : 641-655, 1990

3 Lagendijk J.H, "Tracing, the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites." 29 : 491-497, 1997

4 Ormsby A.H, "The utility of cytokeratin subsets in distinguishing Barrett’s-related oesophaeal adenocarcinoma from gastric adenocarcinoma." 38 : 307-311, 2001

5 Tot T, "The role of cytokeratin 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract." 108 : 467-472, 2000

6 Moll R, "The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells." 31 : 11-24, 1982

7 Abu-Rustum N.R, "The accuracy of frozen-section diagnosis in metastatic breast and colorectal carcinoma to the adnexa." 73 : 102-105, 1999

8 Woodruff J.D, "The Krukenberg tumor: study of 48 cases from the ovarian tumor registry." 15 : 351-360, 1960

9 Ulbright T.M, "Secondary ovarian neoplasia: a clinicopathologic study of 35 cases." 53 : 1164-1174, 1984

10 Kim H.K, "Prognostic factors of Krukenberg’s tumor." 82 : 105-109, 2001

11 Sutton G.P, "Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study." 166 : 50-53, 1992

12 van de Molengraft F.J, "OV-TL 12/30 (keratin 7 antibody) is a marker of glandular differentiation in lung cancer." 22 : 35-38, 1993

13 Young R.H, "Metastatses from carcinomas of the pancreas simulating primary mucinous tumors of the ovary." 13 (13): 748-756, 1989

14 Young R.H, "Metastatic tumors of the ovary. In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract." New York: Springer-Verlag 934-974, 1994

15 Parker R.T, "Metastatic tumors of ovary. In Coppleson M, editor. Gynecologic oncology." New york: Churchill Livingstone 987-999, 1992

16 Yada-Hashimoto N, "Metastatic ovarian tumors: a review of 64 cases." 89 : 314-317, 2003

17 Woodruff J.D, "Metastatic ovarian tumors." 107 : 202-209, 1970

18 Soloway I, "Krukenberg tumors of the ovary: a clinicopathologic analysis of 112 cases." 8 : 636-638, 1956

19 Hale R.W, "Krukenberg tumor of the ovaries: a review of 81 records." 32 : 221-225, 1987

20 Wauters C.C, "Keratin 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary." 26 : 852-855, 1995

21 Miettimen M, "Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinoma." 8 : 384-388, 1995

22 Lash R.H, "Intestinal adenocarcinomas metastatic to the ovaries: a clinicopathologic evaluation of 22 cases." 11 : 114-121, 1987

23 Tabata M, "Incidence of ovarian metastasis in patients with cancer of the uterine cervix." 28 : 225-261, 1987

24 Ueda G, "Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary." 51 : 219-223, 1993

25 Kaufmann O, "Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites." 29 : 233-240, 1996

26 Park S.Y, "Expression of cytokeratin 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary." 33 : 1078-1085, 2002

27 Jarasch E.D, "Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins." 19 : 276-289, 1988

28 Loy T.S, "Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma." 9 : 1040-1044, 1996

29 Chu P, "Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases." 13 (13): 962-972, 2000

30 Berezowski K, "Cytokeratin 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma." 9 : 426-429, 1996

31 Moll R, "Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies." 140 : 427-447, 1992

32 Chan J.K, "Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites." 21 : 226-234, 1997

33 Wang N.P, "Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas." 3 : 99-107, 1995

34 Johansson H, "Clinical aspects of metastatic ovarian cancer of extragenital origin." 39 : 681-697, 1960

35 Webb M.J, "Cancer metastatic to the ovary: factors influencing survival." 45 : 391-396, 1975

36 Tot T, "Adenocarcinomas metastatic to the liver. The value of cytokeratins 20 and 7 in the search for unknown primary tumors." 24 : 870-876, 2000

37 Horie K, "A clinical study of metastatic ovarian tumors." 38 : 435-, 1986